Physician profile
Alex Rainow
NPI 1255577904
$1,266.92
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $989 · 2020: $12.40 · 2021: $54.71 · 2022: $64.80 · 2024: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $223.24 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic Vascular, INC. | $201.07 | 2019 | |
| Heartflow, INC. | $188.99 | 2019-2024 | |
| Boston Scientific Corporation | $153.86 | 2019-2021 | |
| Abbott Laboratories | $127.91 | 2019 | |
| Amgen INC. | $79.34 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $53.74 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.57 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $38.28 | 2019 | |
| Braemar Manufacturing, LLC | $37.94 | 2019 | |
| Pfizer INC. | $29.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $21.39 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $21.20 | 2019 | |
| Portola Pharmaceuticals, LLC | $17.30 | 2019 | |
| Merck Sharp & Dohme LLC | $17.28 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Rainow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.